Sublytic terminal complement complexes stimulate cell cycle activation in Schwann cells

Author： Hafer-Macko C.   Dashiell S.M.   Shin M.   Koski C.L.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2548-2553

Bentham Science Publishers

Access to resources Recommend Favorite

Natural inhibitors of complement amplification: Anti-C3 antibodies from IVIG stimulate inactivation of C3bn-containing complexes

By Lutz H.U.   Stammler P.   Jelezarova E.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

Regulation of B-Cell Activation by Complement Receptors CD21 and CD35

By  

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1849-1860

Bentham Science Publishers

Access to resources Recommend Favorite

B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation

By Liang Xin  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 646-658

Springer Publishing Company

Access to resources Recommend Favorite

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection

By Tanhehco E.J.   Lee H.   Lucchesi B.R.  

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 391-399

Elsevier

Access to resources Recommend Favorite